Mail

Canada markets close in 1 hour 9 minutes

S&P/TSX
22,302.57
+59.23(+0.27%)
S&P 500
5,300.39
+53.71(+1.02%)
DOW
39,835.44
+277.33(+0.70%)
CAD/USD
0.7354
+0.0028(+0.38%)
CRUDE OIL
78.74
+0.72(+0.92%)
Bitcoin CAD
88,839.79
+5,371.10(+6.43%)

MARKETS LIVE BLOG

STOCKS JUMP AFTER U.S. INFLATION REPORT RELEASE

Roundhill Magnificent Seven ETF hit all-time high on Wednesday

Vor Biopharma Inc. (VOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

1.6700

-0.0100

(-0.60%)

As of 02:45PM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	114.68M
Enterprise Value	41.94M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	0.93
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-3.09

Trading Information

Stock Price History

Beta (5Y Monthly)	-0.24
52-Week Change ³	-62.75%
S&P500 52-Week Change ³	26.16%
52 Week High ³	5.7000
52 Week Low ³	1.6200
50-Day Moving Average ³	1.9263
200-Day Moving Average ³	2.1874

Share Statistics

Avg Vol (3 month) ³	336.2k
Avg Vol (10 day) ³	292.03k
Shares Outstanding ⁵	68.26M
Implied Shares Outstanding ⁶	69.07M
Float ⁸	31.93M
% Held by Insiders ¹	1.14%
% Held by Institutions ¹	87.26%
Shares Short (Apr 30, 2024) ⁴	3.68M
Short Ratio (Apr 30, 2024) ⁴	13.86
Short % of Float (Apr 30, 2024) ⁴	9.91%
Short % of Shares Outstanding (Apr 30, 2024) ⁴	5.39%
Shares Short (prior month Mar 28, 2024) ⁴	3.24M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-35.97%
Return on Equity (ttm)	-68.07%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-124.34M
Net Income Avi to Common (ttm)	-120.23M
Diluted EPS (ttm)	-1.7700
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	107.48M
Total Cash Per Share (mrq)	1.58
Total Debt (mrq)	34.74M
Total Debt/Equity (mrq)	28.24%
Current Ratio (mrq)	8.46
Book Value Per Share (mrq)	1.80

Cash Flow Statement

Operating Cash Flow (ttm)	-106.49M
Levered Free Cash Flow (ttm)	-62.33M